New cancer drug ADCX-020 enters first human trials for advanced tumors
NCT ID NCT07238075
First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 18 times
Summary
This early-phase study tests a new cancer drug, ADCX-020, in about 290 adults with advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody-drug conjugate designed to target and kill cancer cells. The study first finds a safe dose, then tests that dose in different cancer types to see if it shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Blacktown Hospital
NOT_YET_RECRUITINGSydney, New South Wales, 2148, Australia
-
Cancer Research SA
NOT_YET_RECRUITINGAdelaide, South Australia, 5000, Australia
-
Macquarie University
NOT_YET_RECRUITINGSydney, New South Wales, 2109, Australia
-
Sunshine Coast University Private Hospital
RECRUITINGBirtinya, Queensland, 4575, Australia
Conditions
Explore the condition pages connected to this study.